Skip to main content
Erschienen in: Digestive Diseases and Sciences 2/2019

27.10.2018 | Editorial

OPeNing the Epithelial Barrier: Osteopontin Preserves Gut Barrier Function During Intestinal Inflammation

verfasst von: Hiroshi Nakase

Erschienen in: Digestive Diseases and Sciences | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Excerpt

Since the pathophysiology of inflammatory bowel disease (IBD) is multifactorial, a systematic approach to identifying the molecular events that provoke and sustain the chronic, recurring inflammation typical of IBD is required. The continuous stimulation of the mucosal immune system due to the increased permeability of the intestinal epithelial cell (IEC) layer may be the primary defect in patients suffering from IBD, whereas a healthy epithelium provides an effective barrier to the penetration of luminal antigens into the submucosa. Increased paracellular permeability has been documented in the epithelial lining from acutely inflamed and chronically damaged areas of the intestine of IBD patients. Numerous animal studies have demonstrated the development of inflammation in intestinal segments underlying “leaky” mucosa and have even reported increased permeability prior to the onset of intestinal inflammation [1, 2]. …
Literatur
1.
Zurück zum Zitat Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521–533.CrossRefPubMed Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521–533.CrossRefPubMed
2.
Zurück zum Zitat Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, Fedorak RN. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis. 1999;5:262–270.CrossRefPubMed Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, Fedorak RN. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis. 1999;5:262–270.CrossRefPubMed
3.
4.
Zurück zum Zitat Iida T, Wagatsuma K, Hirayama D, Nakase H. Is osteopontin a friend or foe of cell apoptosis in inflammatory gastrointestinal and liver diseases? Int J Mol Sci. 2018;19:7.CrossRef Iida T, Wagatsuma K, Hirayama D, Nakase H. Is osteopontin a friend or foe of cell apoptosis in inflammatory gastrointestinal and liver diseases? Int J Mol Sci. 2018;19:7.CrossRef
5.
Zurück zum Zitat Toyonaga T, Nakase H, Ueno S, et al. Osteopontin deficiency accelerates spontaneous colitis in mice with disrupted gut microbiota and macrophage phagocytic activity. PLoS ONE. 2015;10:e0135552.CrossRefPubMedPubMedCentral Toyonaga T, Nakase H, Ueno S, et al. Osteopontin deficiency accelerates spontaneous colitis in mice with disrupted gut microbiota and macrophage phagocytic activity. PLoS ONE. 2015;10:e0135552.CrossRefPubMedPubMedCentral
6.
7.
Zurück zum Zitat Araki Y, Sugihara H, Hattori T. In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanism for dextran sulfate sodium-induced colitis. Oncol Rep. 2006;16:1357–1362.PubMed Araki Y, Sugihara H, Hattori T. In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanism for dextran sulfate sodium-induced colitis. Oncol Rep. 2006;16:1357–1362.PubMed
8.
Zurück zum Zitat Tang R, Yang G, Zhang S, Wu C, Chen M. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:1950–1961.CrossRefPubMed Tang R, Yang G, Zhang S, Wu C, Chen M. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:1950–1961.CrossRefPubMed
9.
Zurück zum Zitat Reinisch W, Panés J, Khurana S, et al. Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomized multicentre study. Gut. 2015;64:894–900.CrossRef Reinisch W, Panés J, Khurana S, et al. Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomized multicentre study. Gut. 2015;64:894–900.CrossRef
10.
Zurück zum Zitat Krug SM, Bojarski C, Fromm A, et al. Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis. Mucosal Immunol. 2018;11:345–356.CrossRefPubMed Krug SM, Bojarski C, Fromm A, et al. Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis. Mucosal Immunol. 2018;11:345–356.CrossRefPubMed
11.
Zurück zum Zitat Krug SM, Schilzke JD, Fromm M. Tight junction, selective permeability, and related diseases. Semin Cell Dev Biol. 2014;36:166–176.CrossRefPubMed Krug SM, Schilzke JD, Fromm M. Tight junction, selective permeability, and related diseases. Semin Cell Dev Biol. 2014;36:166–176.CrossRefPubMed
12.
Zurück zum Zitat Stamatovic SM, Johnson AM, Sladojevic N, Keep RF, Andjelkovic AV. Endocytosis of tight junction proteins and the regulation of degradation and recycling. Ann N Y Acad Sci. 2017;1397:54–65.CrossRefPubMedPubMedCentral Stamatovic SM, Johnson AM, Sladojevic N, Keep RF, Andjelkovic AV. Endocytosis of tight junction proteins and the regulation of degradation and recycling. Ann N Y Acad Sci. 2017;1397:54–65.CrossRefPubMedPubMedCentral
Metadaten
Titel
OPeNing the Epithelial Barrier: Osteopontin Preserves Gut Barrier Function During Intestinal Inflammation
verfasst von
Hiroshi Nakase
Publikationsdatum
27.10.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 2/2019
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5350-7

Weitere Artikel der Ausgabe 2/2019

Digestive Diseases and Sciences 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.